Johnson & Johnson
USD258.51
+3.85 (+1.51%)
CEO
Joaquin Duato
IPO Date
1962-01-02
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$253.19
Prev. Close
$254.66
Day Low
$252.03
Day High
$258.58
52W Low
$151.52
52W High
$258.58
Market Cap
$622.29B
Volume
8.44M
| 24.5 |
| 31 Dec 2023 | FY | 68.8% | 41.3% | 51.1% | 21.0% | 0.43 | 1.16 | 11.3 |
| 1 Jan 2023 | FY | 69.3% | 22.4% | 23.4% | 9.6% | 0.52 | 0.99 | 25.7 |
| 2 Jan 2022 | FY | 70.3% | 26.5% | 28.2% | 11.5% | 0.46 | 1.35 | 21.6 |
| 3 Jan 2021 | FY | 65.6% | 17.8% | 23.3% | 8.4% | 0.56 | 1.21 | 28.0 |
| 31 Dec 2019 | FY | 66.4% | 18.4% | 25.4% | 9.6% | 0.47 | 1.26 | 25.4 |
| 31 Dec 2018 | FY | 66.8% | 18.8% | 25.6% | 10.0% | 0.51 | 1.47 | 22.5 |
| 31 Dec 2017 | FY | 66.7% | 1.7% | 2.2% | 0.8% | 0.57 | 1.41 | 288.3 |
| 31 Dec 2016 | FY | 69.7% | 23.0% | 23.5% | 11.7% | 0.39 | 2.47 | 18.9 |
| 24.6 |
| 28 Sept 2025 | Q3 | 69.6% | 21.5% | 6.5% | 2.7% | 0.58 | 1.07 | 21.4 |
| 29 Jun 2025 | Q2 | 67.9% | 23.3% | 7.1% | 2.9% | 0.65 | 1.01 | 16.7 |
| 30 Mar 2025 | Q1 | 66.4% | 50.2% | 14.1% | 5.7% | 0.67 | 1.26 | 9.1 |
| 29 Dec 2024 | Q4 | 68.3% | 15.2% | 4.8% | 1.9% | 0.51 | 1.11 | 25.1 |
| 29 Sept 2024 | Q3 | 69.0% | 12.0% | 3.8% | 1.5% | 0.51 | 1.03 | 36.2 |
| 30 Jun 2024 | Q2 | 69.4% | 20.9% | 6.6% | 2.6% | 0.58 | 1.07 | 18.8 |
| 31 Mar 2024 | Q1 | 69.6% | 15.2% | 4.6% | 1.9% | 0.48 | 1.17 | 29.2 |
| 31 Dec 2023 | Q4 | 68.2% | 18.9% | 5.9% | 2.4% | 0.43 | 1.16 | 23.3 |